In two consecutive experiences, Logozzi et al. demonstrated that analyzing PSA-expressing exosomes provides an incredibly accurate way to discriminate between healthy patients and those with prostate disease, and even within the latter group, it can differentiate between patients affected by BPH and PC [22,23]. Here, KLK3 is linked to benign prostatic hyperplasia.